545 related articles for article (PubMed ID: 31988582)
1. Novel methylation gene panel in adjacent normal tissues predicts poor prognosis of colorectal cancer in Taiwan.
Hsu CH; Hsiao CW; Sun CA; Wu WC; Yang T; Hu JM; Huang CH; Liao YC; Chen CY; Lin FH; Chou YC
World J Gastroenterol; 2020 Jan; 26(2):154-167. PubMed ID: 31988582
[TBL] [Abstract][Full Text] [Related]
2. Multiple gene promoter methylation and clinical stage in adjacent normal tissues: Effect on prognosis of colorectal cancer in Taiwan.
Hsu CH; Hsiao CW; Sun CA; Wu WC; Yang T; Hu JM; Liao YC; Huang CH; Chen CY; Lin FH; Chou YC
Sci Rep; 2020 Jan; 10(1):145. PubMed ID: 31924802
[TBL] [Abstract][Full Text] [Related]
3. Clinical stage and risk of recurrence and mortality: interaction of DNA methylation factors in patients with colorectal cancer.
Chang HF; Wu CC; Sun CA; Chu CM; Lin FG; Hsieh JF; Hsu CH; Huang CH; Yang T; Tsai YM; Kuan JC; Chou YC
J Investig Med; 2016 Oct; 64(7):1200-7. PubMed ID: 27296458
[TBL] [Abstract][Full Text] [Related]
4. Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array.
Lin PC; Lin JK; Lin CH; Lin HH; Yang SH; Jiang JK; Chen WS; Chou CC; Tsai SF; Chang SC
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1419-27. PubMed ID: 25472652
[TBL] [Abstract][Full Text] [Related]
5. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
6. DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis.
Tsai MH; Chen WC; Yu SL; Chen CC; Jao TM; Huang CY; Tzeng ST; Yen SJ; Yang YC
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1481-9. PubMed ID: 25968618
[TBL] [Abstract][Full Text] [Related]
7. Stage-differentiated ensemble modeling of DNA methylation landscapes uncovers salient biomarkers and prognostic signatures in colorectal cancer progression.
Muthamilselvan S; Raghavendran A; Palaniappan A
PLoS One; 2022; 17(2):e0249151. PubMed ID: 35202405
[TBL] [Abstract][Full Text] [Related]
8. Promoter hypomethylation of RAR-related orphan receptor α 1 is correlated with unfavorable clinicopathological features in patients with colorectal cancer.
Kano H; Takayama T; Midorikawa Y; Nagase H
Biosci Trends; 2016 Jul; 10(3):202-9. PubMed ID: 27301432
[TBL] [Abstract][Full Text] [Related]
9. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
[TBL] [Abstract][Full Text] [Related]
10. Involvement of methylation-associated silencing of formin 2 in colorectal carcinogenesis.
Li DJ; Feng ZC; Li XR; Hu G
World J Gastroenterol; 2018 Nov; 24(44):5013-5024. PubMed ID: 30510376
[TBL] [Abstract][Full Text] [Related]
11. Promoter Methylation Status of Two Novel Human Genes, UBE2Q1 and UBE2Q2, in Colorectal Cancer: a New Finding in Iranian Patients.
Mokarram P; Shakiba-Jam F; Kavousipour S; Sarabi MM; Seghatoleslam A
Asian Pac J Cancer Prev; 2015; 16(18):8247-52. PubMed ID: 26745068
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a lipogenic genes panel for diagnosis and recurrence of colorectal cancer.
Gharib E; Nasrinasrabadi P; Zali MR
PLoS One; 2020; 15(3):e0229864. PubMed ID: 32155177
[TBL] [Abstract][Full Text] [Related]
13. Methylation associated transcriptional repression of ELOVL5 in novel colorectal cancer cell lines.
Boot A; Oosting J; van Eendenburg JDH; Kuppen PJK; Morreau H; van Wezel T
PLoS One; 2017; 12(9):e0184900. PubMed ID: 28931069
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation combinations in adjacent normal colon tissue predict cancer recurrence: evidence from a clinical cohort study.
Kuan JC; Wu CC; Sun CA; Chu CM; Lin FG; Hsu CH; Kan PC; Lin SC; Yang T; Chou YC
PLoS One; 2015; 10(3):e0123396. PubMed ID: 25815725
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.
Chang SC; Liew PL; Ansar M; Lin SY; Wang SC; Hung CS; Chen JY; Jain S; Lin RK
Clin Epigenetics; 2020 May; 12(1):67. PubMed ID: 32398064
[TBL] [Abstract][Full Text] [Related]
16. Identifying CpG sites with different differential methylation frequencies in colorectal cancer tissues based on individualized differential methylation analysis.
Yan H; He J; Guan Q; Cai H; Zhang L; Zheng W; Qi L; Zhang S; Liu H; Li H; Zhao W; Yang S; Guo Z
Oncotarget; 2017 Jul; 8(29):47356-47364. PubMed ID: 28537885
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of fibulin-3 gene by promoter methylation in colorectal cancer predicts adverse prognosis.
Tong JD; Jiao NL; Wang YX; Zhang YW; Han F
Neoplasma; 2011; 58(5):441-8. PubMed ID: 21744999
[TBL] [Abstract][Full Text] [Related]
18. CDH13 and FLBN3 gene methylation are associated with poor prognosis in colorectal cancer.
Wang Z; Yuan X; Jiao N; Zhu H; Zhang Y; Tong J
Pathol Oncol Res; 2012 Apr; 18(2):263-70. PubMed ID: 21796503
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
[TBL] [Abstract][Full Text] [Related]
20. A novel miR-203-DNMT3b-ABCG2 regulatory pathway predisposing colorectal cancer development.
To KK; Leung WW; Ng SS
Mol Carcinog; 2017 Feb; 56(2):464-477. PubMed ID: 27253631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
